Most Chemotherapy Administration Sites Are Rural: Evidence From the Minnesota All-Payer Claims Database and a Framework for State-Level Cancer Care Surveillance
PURPOSE: Chemotherapy is widely assumed to be concentrated in urban cancer centers, but state-level data on its geographic distribution are limited. We used the Minnesota All-Payer Claims Database (MN APCD) to characterize rural and urban chemotherapy administration sites, assess quality certification rates, and present a replicable methodology for other states. METHODS: Claims for carboplatin (J9045) and paclitaxel (J9264, J9267) from the 2022 MN APCD were analyzed. Chemotherapy administration sites were identified from billing claims, geolocated, and assigned Rural-Urban Commuting Area (RUCA) codes (urban: 1-3; rural: 4-10). Quality Oncology Practice Initiative (QOPI) certification and Commission on Cancer (CoC) accreditation were matched by facility. National QOPI (N = 217) and CoC (N = 1,093) data were analyzed by RUCA category for comparison. RESULTS: 42.9%). Nationally, rural practices comprised 14.7% of QOPI-certified sites and 13.4% of CoC-accredited programs, 15%-20% of the US population living in rural areas. CONCLUSION: Despite published ASCO workforce data showing that only 7%-11.7% of medical oncologists practice in rural areas, 52.9% of Minnesota chemotherapy administration sites are rural, challenging the assumption that chemotherapy delivery is an urban and suburban phenomenon. Rural sites deliver 27.0% of claim volume, suggesting a broadly distributed but lower-intensity rural oncology infrastructure invisible to workforce-based mapping. This APCD-based framework is scalable and replicable; with approximately 25 states operating or developing mandatory APCDs, it can inform cancer control planning, direct resources to where care is delivered, and help close rural oncology disparities nationwide.
Authors
- Joshua C. Pritchett (ORCID: https://orcid.org/0000-0001-6139-5526)
- Wade Thomas Swenson (ORCID: https://orcid.org/0000-0002-2121-7917)
- Aquino Williams (ORCID: https://orcid.org/0000-0003-4666-4120)
- Abigail Paige Swenson (ORCID: https://orcid.org/0000-0003-1475-2687)
- Zachary Schroeder (ORCID: https://orcid.org/0000-0001-9899-117X)
- Ingrid E. Jacobson (ORCID: https://orcid.org/0000-0003-0199-9082)
- Gillian A. Northrup (ORCID: https://orcid.org/0009-0003-5487-2816)
- Anika Eldien (ORCID: https://orcid.org/0009-0002-1312-9092)
- Collin Kray
- Andrew Foster Armstrong (ORCID: https://orcid.org/0009-0003-1320-6374)
- Mark Mitchell
- Aidan Swenson
Institutions
- Texas Christian University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Tennessee Health Science Center (US)
- Medical College of Wisconsin (US)
- University of Minnesota, Duluth (US)
- Wake Forest University Health Sciences (US)
- Rural Cancer Institute (US)
- Wake Forest University (US)
- College of Saint Benedict and Saint John's University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1200/op-26-00505
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00